Cetera Advisors LLC lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 5.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,286 shares of the healthcare conglomerate’s stock after selling 626 shares during the period. Cetera Advisors LLC’s holdings in UnitedHealth Group were worth $2,220,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Marshall Wace LLP grew its holdings in UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after acquiring an additional 11,361 shares during the period. American Century Companies Inc. grew its holdings in UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after acquiring an additional 681,111 shares during the period. DekaBank Deutsche Girozentrale grew its holdings in UnitedHealth Group by 2.0% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after acquiring an additional 9,810 shares during the period. Essex Financial Services Inc. grew its holdings in UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after acquiring an additional 967 shares during the period. Finally, Bainco International Investors grew its holdings in UnitedHealth Group by 5.4% during the 3rd quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after acquiring an additional 4,202 shares during the period. 86.24% of the stock is owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Inc (UNH) opened at $220.96 on Friday. The company has a market cap of $218,580.00, a price-to-earnings ratio of 20.63, a P/E/G ratio of 1.26 and a beta of 0.70. UnitedHealth Group Inc has a 52-week low of $156.49 and a 52-week high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The firm’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 EPS. equities analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders sold a total of 53,853 shares of company stock worth $12,358,508 over the last ninety days. 0.89% of the stock is currently owned by insiders.

A number of analysts have commented on the stock. Leerink Swann reaffirmed a “buy” rating and set a $240.00 target price (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Wells Fargo & Co reaffirmed an “outperform” rating and set a $245.00 target price (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, Citigroup lifted their target price on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $243.22.

TRADEMARK VIOLATION WARNING: “Cetera Advisors LLC Lowers Position in UnitedHealth Group Inc (UNH)” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://theolympiareport.com/2018/02/11/cetera-advisors-llc-lowers-position-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.